rs148833471
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_002461.3(MVD):c.1104A>G(p.Lys368Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00717 in 1,599,146 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0049 ( 4 hom., cov: 34)
Exomes 𝑓: 0.0074 ( 46 hom. )
Consequence
MVD
NM_002461.3 synonymous
NM_002461.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.628
Genes affected
MVD (HGNC:7529): (mevalonate diphosphate decarboxylase) The enzyme mevalonate pyrophosphate decarboxylase catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate in one of the early steps in cholesterol biosynthesis. It decarboxylates and dehydrates its substrate while hydrolyzing ATP. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-88653318-T-C is Benign according to our data. Variant chr16-88653318-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 790328.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.628 with no splicing effect.
BS2
High AC in GnomAd4 at 739 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MVD | NM_002461.3 | c.1104A>G | p.Lys368Lys | synonymous_variant | Exon 9 of 10 | ENST00000301012.8 | NP_002452.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MVD | ENST00000301012.8 | c.1104A>G | p.Lys368Lys | synonymous_variant | Exon 9 of 10 | 1 | NM_002461.3 | ENSP00000301012.3 | ||
MVD | ENST00000565149.5 | n.1663A>G | non_coding_transcript_exon_variant | Exon 5 of 6 | 1 | |||||
MVD | ENST00000561895.1 | n.385A>G | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 | |||||
MVD | ENST00000562981.1 | n.267A>G | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00486 AC: 739AN: 152106Hom.: 4 Cov.: 34
GnomAD3 genomes
AF:
AC:
739
AN:
152106
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00491 AC: 1146AN: 233340Hom.: 2 AF XY: 0.00502 AC XY: 640AN XY: 127610
GnomAD3 exomes
AF:
AC:
1146
AN:
233340
Hom.:
AF XY:
AC XY:
640
AN XY:
127610
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00741 AC: 10723AN: 1446922Hom.: 46 Cov.: 32 AF XY: 0.00732 AC XY: 5274AN XY: 720102
GnomAD4 exome
AF:
AC:
10723
AN:
1446922
Hom.:
Cov.:
32
AF XY:
AC XY:
5274
AN XY:
720102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00485 AC: 739AN: 152224Hom.: 4 Cov.: 34 AF XY: 0.00498 AC XY: 371AN XY: 74428
GnomAD4 genome
AF:
AC:
739
AN:
152224
Hom.:
Cov.:
34
AF XY:
AC XY:
371
AN XY:
74428
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
MVD: BP4, BP7, BS2 -
Oct 05, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at